UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

~~WASHINGTON~~Washington, DCD.C. 20549

______________

FORM 8-K

~~______________~~CURRENT REPORT

~~CURRENT~~Pursuant ~~REPORT~~to ~~PURSUANT~~Section 13 or 15(d) of the Securities Exchange Act of 1934

TODate ~~SECTION~~of Report 13(Date ORof ~~15(d~~earliest event reported): OFOctober ~~THE~~23, 2007

SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest reported): April 23, 2007

______________

AVVAA WORLD HEALTH CARE PRODUCTS, INC.

(~~Exact~~EXACT ~~Name~~NAME ofOF ~~Registrant~~REGISTRANT asAS ~~Specified~~SPECIFIED inIN ~~Its Charter~~CHARTER)

NEVADA	000-31611	88-395714
Nevada	000-31611	88-395714
(State or Other Jurisdiction of Incorporation)	(Commission File Number)	(IRS Employer Identification No.)
(State or other jurisdiction of incorporation or organization)	(Commission File Number)	(IRS Employee Identification No.)

Box 459, 1710 Shuswap Ave

Box 459, 1710 Shuswap Ave Lumby, BC, Canada V0E 2G0	V0E 2G0
(Address of principal executive offices)	(Zip Code)

~~Lumby~~Registrant’s telephone number, ~~BC,~~ ~~Canada~~including ~~V0E~~area ~~2G0~~code: (250) 547-2048

~~(Address~~Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of ~~Principal~~the ~~Executive~~registrant ~~Offices)~~under any of the following provisions (~~Zip~~see ~~Code~~General Instruction A.2. below):

~~(250)~~[ ~~547-2048~~] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

~~(Registrant’s~~[ ~~Telephone~~] Soliciting ~~Number,~~material ~~Including~~pursuant ~~Area~~to ~~Code~~Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

~~(Former~~[ ~~Name~~] Pre-commencement orcommunications ~~Former~~pursuant ~~Address,~~to ifRule ~~Changed~~14d-2(b) ~~Since~~under ~~Last~~the ~~Report~~Exchange Act (17 CFR 240.14d-2(b))

~~===============================================================~~[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

~~FORWARD~~ITEM ~~LOOKING~~4.02 Non-Reliance ~~STATEMENTS~~on Previously Issued Financial Statements or a Related Audit Report.

~~This~~On ~~Form 8-K~~October ~~and~~23, ~~other~~our ~~reports~~Chief ~~filed~~Executive byOfficer ~~Registrant~~and ~~from~~sole ~~time~~director, toJohn ~~time~~S. ~~with the Securities~~Farley ~~and~~determined ~~Exchange~~that ~~Commission~~our ~~(collectively~~financial ~~the “Filings”) contain or may contain forward looking~~ statements ~~and~~for ~~information~~the ~~that~~fiscal ~~are~~years ~~based~~ended ~~upon~~May ~~beliefs of~~31, ~~and~~2005 ~~information~~and ~~currently~~2006 ~~available to, Registrant’s management as well as estimates~~ and ~~assumptions~~for ~~made by Registrant’s management. When used in~~ the ~~filings~~quarters ~~the words~~ended ~~“anticipate”,~~August ~~“believe”~~31, ~~“estimate”,~~November ~~“expect”~~30, ~~“future”, “intend”, “plan” or the negative of these terms~~ and ~~similar~~February expressions as they relate to Registrant or Registrant’s management identify forward looking statements. Such statements reflect the current view of Registrant with respect to future events and are subject to risks28, ~~uncertainties, assumptions and other factors relating~~ toduring ~~Registrant’s~~fiscal ~~industry,~~years ~~Registrant’s~~2006 ~~operations~~ and ~~results~~2007 ofcould ~~operations~~no ~~and any~~longer ~~businesses that may~~ be ~~acquired~~relied ~~by Registrant~~upon. Should one or more of these risks or uncertainties materialize, or should the underlying assumptions prove incorrect, actual results may differ significantly from those anticipated, believed, estimated, expected, intended or planned.

~~Although~~In ~~Registrant~~this regard, ~~believes~~during ~~that~~ the ~~expectations~~preparation ~~reflected~~of inits ~~the~~May ~~forward~~31, ~~looking~~2007 consolidated financial statements, ~~are~~the ~~reasonable,~~Company ~~Registrant~~concluded ~~cannot~~that ~~guarantee~~it ~~future~~was ~~results,~~necessary ~~levels~~to restate its financial ~~of activity,~~results ~~performance~~for orthe ~~achievements.~~fiscal ~~Except~~years asended ~~required~~May by31, ~~applicable~~2006 ~~law,~~and 2005 and for the interim ~~including~~periods ~~the~~ended ~~securities~~August ~~laws~~31, ofNovember ~~the~~30, ~~United~~and ~~States~~February 28, ~~Registrant~~during ~~does~~fiscal ~~not~~2007 ~~intend~~and 2006 to ~~update~~reflect ~~any~~additional ofnon-operating ~~the~~gains ~~forward-looking~~and ~~statements~~losses related to ~~conform~~the classification ~~these~~of ~~statements~~and accounting for convertible notes issued in fiscal 2006 toand ~~actual~~2005. The ~~results~~Company had previously recorded a beneficial conversion feature, valued the conversion features and detachable warrants at the intrinsic value and classified the convertible instruments as equity.

~~ITEM~~After 5further review, the Company has determined that these instruments should have been classified as derivative liabilities pursuant to SFAS No.02 ~~DEPARTURE~~133 OFand ~~DIRECTORS~~EITF No. 00-19. The ORaccounting ~~PRINCIPAL~~treatment ~~OFFICERS;~~of ~~ELECTION~~derivative OFfinancial ~~DIRECTORS;~~instruments ~~APPOINTMENT~~requires OFthat ~~PRINCIPAL~~the ~~OFFICERS~~Company record the derivatives and related warrants at their fair values as of the inception date of and at fair value as of each subsequent balance sheet date. At the date of the conversion of each respective instrument or portion thereof, the corresponding derivative liability will be reclassified as equity.

~~Effective~~In ~~April 23~~ particular, ~~2007,~~financial ~~Dr.~~statements ~~Mark~~for ~~Alden,~~the ~~William~~fiscal ~~Douglas~~years ~~Ernsberger,~~ended ~~James~~May ~~MacDonald~~31, 2005 and ~~James~~ 2006 ~~Haney~~and ~~resigned~~for ~~from~~ the ~~Board~~quarters ofended ~~Directors~~August ~~(“Board”)~~31, ofNovember ~~avVaa~~30, ~~World~~and ~~Health Care~~February ~~Products~~28, ~~Inc.~~during fiscal ~~(the~~years ~~“Company”).~~2006 Toand ~~the~~2007 ~~knowledge~~will ofbe ~~the~~restated ~~Board~~to ~~and~~reflect ~~executive officers of~~ the ~~Company, neither Dr. Alden, Mr. Ernsberger, Mr. MacDonald,~~additional ~~nor Mr.~~ non-operating ~~Haney~~gains ~~resigned~~and ~~because~~losses ofrelated ~~any~~additional ~~disagreement~~penalties ~~with~~relating ~~the Company on any matter~~to ~~related~~ convertible tonotes ~~the Company’s operations, policies or practices~~outstanding.

~~Additionally,~~The ~~Mr.~~ sole executive ~~Charles~~officer ~~Austin resigned from the Board~~ of ~~Directors of~~ the ~~Company~~company ~~as well as~~discussed ~~his positions as Secretary, Chief Financial Officer and Chief Accounting Officer~~ with the Company.’s Toindependent auditors the ~~knowledge~~matters ofdisclosed ~~the~~in ~~Board~~this ~~and~~Item ~~executive officers of the Company, Mr~~4.02 ~~Austin did not resign because~~ of ~~any disagreement with~~ the ~~Company~~ onForm ~~any matter related to the Company’s operations, policies or practices~~8-K.

~~ITEM~~ Item 9.01. ~~FINANCIAL~~Financial ~~STATEMENTS~~Statement ~~AND~~And ~~EXHIBITS~~Exhibits.

(a) ~~Exhibits~~Financial Statements of Business Acquired.

None.

(b)	Pro Forma Financial Information.

None

(c)

Exhibits.

None.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the ~~registrant~~Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.

AVVAA WORLD HEALTH CARE PRODUCTS, INC.

	AVVAA WORLD HEALTH CARE PRODUCTS, INC.

Dated: November 1, 2007	By:	/s/ John Farley
		JOHN FARLEY Chief Executive Officer

By: /s/ John Farley John Farley, Chairman

May 10, 2007

Filing Compare · AVVAA WORLD HEALTH CARE PRODUCTS INC